Compounds > celecoxib
Page last updated: 2024-10-24

celecoxib and Inflammatory Response Syndrome, Systemic

celecoxib has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment with Molsidomine reduced mortality to 0%, decreased BT, MPO, pro-inflammatory cytokines and OFR (p<."1.43Comparative study of bacterial translocation control with nitric oxide donors and COX2 inhibitor. ( García-Cenador, MB; García-Criado, FJ; García-García, MI; García-Moro, M; García-Sánchez, E; García-Sánchez, JE; Lorenzo-Gómez, MF; Lozano-Sánchez, F; Sánchez-Conde, MP, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Cenador, MB1
Lorenzo-Gómez, MF1
García-Moro, M1
García-García, MI1
Sánchez-Conde, MP1
García-Criado, FJ1
García-Sánchez, E1
Lozano-Sánchez, F1
García-Sánchez, JE1

Other Studies

1 other study available for celecoxib and Inflammatory Response Syndrome, Systemic

ArticleYear
Comparative study of bacterial translocation control with nitric oxide donors and COX2 inhibitor.
    Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:8

    Topics: Animals; Bacterial Translocation; Celecoxib; Cyclooxygenase 2 Inhibitors; Male; Molsidomine; Nitric

2016